Drugs / bacille Calmette-Guerin
bacille Calmette-Guerin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00480688 | Nov 2001 → May 2002 | tuberculosis | University of Oxford | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bacille Calmette-Guerin | “bacille Calmette-Guerin (BCG)” PMID 15502839 ↗ Oct 2004 |
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00480688 ↗ |
| Known as | M. bovis BCG | “M. bovis BCG is a fully licensed vaccine that has been in routine clinical use for the last 50 years.” NCT00480688 ↗ |
| Modality | Vaccine | “M. bovis BCG is a fully licensed vaccine” NCT00480688 ↗ |
| Route | Other | “Delivered Intradermally” NCT00480688 ↗ |